Skip to main content

Table 2 Correlation between MRS scores at different time points (weeks 1, 2, and ≥4) after initiation of IVIG therapy and the immunological parameters such as IL-33, Treg cells, and PGE2 at week 1. The values in the parenthesis denote statistical significance

From: Regulatory T cell frequency, but not plasma IL-33 levels, represents potential immunological biomarker to predict clinical response to intravenous immunoglobulin therapy

r values
(p values)
MRS (week post-IVIG)
  Week 1 2 ≥4
IL-33 1 0.57 (0.14) −0.60 (0.20) 0.71 (0.42)
Treg cell 1 −0.37 (0.3601) −0.61 (0.1067) −0.47 (0.0684)
PGE2 1 −0.16 (0.6954) −0.29 (0.4361) −0.07 (0.8936)